Truist Securities Reiterates Hold on Insulet, Raises Price Target to $160

Benzinga · 11/09 14:11
Truist Securities analyst Richard Newitter reiterates Insulet (NASDAQ:PODD) with a Hold and raises the price target from $153 to $160.